FDA Warns About Risk Involving Rare Nerve Syndrome And Johnson & Johnson Vaccine

Credit: CBS 11 Dallas

Duration: 01:30s 13 Jul 2021 0 shares 5 views

FDA Warns About Risk Involving Rare Nerve Syndrome And Johnson & Johnson Vaccine

The Food and Drug Administration has issued a warning about the risk of the rare disease Guillain-Barre Syndrome and the Johnson & Johnson vaccine.

You might like

Related news coverage

Poway mom develops rare nerve disorder after J&J vaccine

Poway mom develops rare nerve disorder after J&J vaccine

ABC 10 News | San Diego 15 Jul 2021

A Poway mother says she was diagnosed with a rare neurological condition after receiving the Johnson & Johnson vaccine.

Experts break down signs of rare side effect reported after J&J vaccine

Experts break down signs of rare side effect reported after J&J vaccine

ABC Action News

13 Jul 2021

FDA Issues New Warning About Johnson & Johnson Vaccine

FDA Issues New Warning About Johnson & Johnson Vaccine

CBS4 Miami

13 Jul 2021

FDA Adds Warning Of Rare Reaction Risk For J&J Vaccine

FDA Adds Warning Of Rare Reaction Risk For J&J Vaccine

KDKA CBS 2 Pittsburgh

13 Jul 2021

FDA issues warning on Johnson & Johnson COVID-19 vaccine side effect

FDA issues warning on Johnson & Johnson COVID-19 vaccine side effect

WCVB

13 Jul 2021

Advertisement

More coverage

FDA issues warning on Johnson & Johnson COVID-19 vaccine side effect

FDA issues warning on Johnson & Johnson COVID-19 vaccine side effect

WCVB 13 Jul 2021

Johnson & Johnson's COVID-19 vaccine may pose a "small possible risk" of a rare but potentially dangerous neurological reaction,..

Vaccine Warning Issued About Johnson And Johnson COVID Vaccine

Vaccine Warning Issued About Johnson And Johnson COVID Vaccine

CBS 13 Sacramento

13 Jul 2021

CDC, FDA Looking Into Risk Of Nerve Complication After Johnson & Johnson COVID-19 Vaccine

CDC, FDA Looking Into Risk Of Nerve Complication After Johnson & Johnson COVID-19 Vaccine

WBZ CBS Boston

12 Jul 2021